These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35538268)

  • 1. Patient perspectives on window of opportunity clinical trials in early-stage breast cancer.
    Parikh DA; Kody L; Brain S; Heditsian D; Lee V; Curtis C; Karin MR; Wapnir IL; Patel MI; Sledge GW; Caswell-Jin JL
    Breast Cancer Res Treat; 2022 Jul; 194(1):171-178. PubMed ID: 35538268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attitudes and barriers to participation in window-of-opportunity trials reported by White and Asian/Asian British ethnicity patients who have undergone treatment for endometrial cancer.
    Mandane B; Amirthanayagam A; Patel N; Darko N; Moss EL
    Trials; 2023 Nov; 24(1):754. PubMed ID: 38007461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspectives on Oncology-Specific Language During the Coronavirus Disease 2019 Pandemic: A Qualitative Study.
    Gharzai LA; Resnicow K; An LC; Jagsi R
    JAMA Oncol; 2020 Sep; 6(9):1424-1428. PubMed ID: 32761102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facilitators and barriers to reducing chemotherapy for early-stage breast cancer: a qualitative analysis of interviews with patients and patient advocates.
    Andrews C; Childers TC; Wiseman KD; Lawhon V; Ingram S; Smith ML; Wolff AC; Wagner L; Rocque GB
    BMC Cancer; 2022 Feb; 22(1):141. PubMed ID: 35120494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
    Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
    Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How informed is declared altruism in clinical trials? A qualitative interview study of patient decision-making about the QUEST trials (Quality of Life after Mastectomy and Breast Reconstruction).
    Bidad N; MacDonald L; Winters ZE; Edwards SJ; Emson M; Griffin CL; Bliss J; Horne R
    Trials; 2016 Sep; 17(1):431. PubMed ID: 27590594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors impacting participation in research during the COVID-19 pandemic: results from a survey of patients in the ophthalmology outpatient department.
    Abdulhussein D; Yap TE; Manzar H; Miodragovic S; Cordeiro F
    Trials; 2022 Sep; 23(1):823. PubMed ID: 36175935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Perspectives on the Access and Effectiveness of Psychosocial Services Offered in the Context of Breast Cancer: A Qualitative Study of Patient's Experience Before and During the COVID-19 Pandemic].
    Fortin J; Defer C; Brunet A; Montreuil M; Marin MF
    Sante Ment Que; 2024; 49(1):27-48. PubMed ID: 39208218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research recruitment and consent methods in a pandemic: a qualitative study of COVID-19 patients' perspectives.
    Small SS; Lau E; McFarlane K; Archambault PM; Longstaff H; Hohl CM
    BMC Med Res Methodol; 2023 May; 23(1):113. PubMed ID: 37170077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What can we learn from trial decliners about improving recruitment? Qualitative study.
    Hughes-Morley A; Young B; Hempel RJ; Russell IT; Waheed W; Bower P
    Trials; 2016 Oct; 17(1):494. PubMed ID: 27733181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient perspectives on chemotherapy de-escalation in breast cancer.
    Rocque GB; Williams CP; Andrews C; Childers TC; Wiseman KD; Gallagher K; Tung N; Balch A; Lawhon VM; Ingram SA; Brown T; Kaufmann T; Smith ML; DeMichele A; Wolff AC; Wagner L
    Cancer Med; 2021 May; 10(10):3288-3298. PubMed ID: 33932097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors that impact on recruitment to vaccine trials in the context of a pandemic or epidemic: a qualitative evidence synthesis.
    Meskell P; Biesty LM; Dowling M; Roche K; Meehan E; Glenton C; Devane D; Shepperd S; Booth A; Cox R; Chan XHS; Houghton C
    Cochrane Database Syst Rev; 2023 Sep; 9(9):MR000065. PubMed ID: 37655964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant chemotherapy in elderly women with breast cancer: patients' perspectives on information giving and decision making.
    Harder H; Ballinger R; Langridge C; Ring A; Fallowfield LJ
    Psychooncology; 2013 Dec; 22(12):2729-35. PubMed ID: 23813806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspectives of patients undergoing neoadjuvant chemotherapy for breast cancer during the COVID-19 pandemic.
    Gaughan AA; MacEwan SR; Rush LJ; Gatti-Mays ME; Pariser AC; McAlearney AS
    Cancer Rep (Hoboken); 2023 Oct; 6(10):e1882. PubMed ID: 37584345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors that impact on recruitment to randomised trials in health care: a qualitative evidence synthesis.
    Houghton C; Dowling M; Meskell P; Hunter A; Gardner H; Conway A; Treweek S; Sutcliffe K; Noyes J; Devane D; Nicholas JR; Biesty LM
    Cochrane Database Syst Rev; 2020 Oct; 10(10):MR000045. PubMed ID: 33026107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial.
    Garcia-Vicuña R; Abad-Santos F; González-Alvaro I; Ramos-Lima F; Sanz JS
    Trials; 2020 Sep; 21(1):772. PubMed ID: 32907638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Something Good Has to Come Out of the Horror": A Qualitative Examination of Cancer Survivors' Attitudes Towards Participation in Research During the First Year of the COVID-19 Pandemic.
    Fox L; Wylie H; Haire A; Green S; Kibaru J; Van Hemelrijck M
    Front Public Health; 2021; 9():741188. PubMed ID: 34778175
    [No Abstract]   [Full Text] [Related]  

  • 20. Critical decisions: A mixed-methods study of decision-making among diverse gynecologic cancer patients considering therapeutic clinical trial enrollment.
    Rieder SM; Burgess E; Rutledge T; Sussman A; Boyce T; Pankratz VS; Kano M
    Gynecol Oncol; 2024 May; 184():103-110. PubMed ID: 38301308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.